Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC CM-579 trihydrochloride | 2448471-08-5 | MFCD07996200 | 97.0% | 602.04 | C29H43Cl3N4O3 | 50 MG
SDP

Catalog No. 5000228664
Encompass_Preferred

CM-579 trihydrochloride is a research reagent that functions as a reversible, dual inhibitor of the histone methyltransferase G9a and DNA methyltransferases (DNMT). Supplied as the trihydrochloride salt at 97.0% purity and a molecular weight of 602.04, it is intended for in vitro biochemical and cellular epigenetic studies.

  • Reversible, dual inhibition of G9a and DNMT.
  • High purity (97.0%) suitable for research assays.
  • Supplied as a trihydrochloride salt for improved stability.
  • Available in small-scale quantities for screening, for example 50 MG.
  • Suitable for biochemical and cellular assay applications.

Catalog No. 50-002-28664 Supplier Medchemexpress LLC Supplier No. HY117421A50MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

CM-579 trihydrochloride is a research reagent that functions as a reversible, dual inhibitor of the histone methyltransferase G9a and DNA methyltransferases (DNMT). Supplied as the trihydrochloride salt at 97.0% purity and a molecular weight of 602.04, it is intended for in vitro biochemical and cellular epigenetic studies.

  • Reversible, dual inhibition of G9a and DNMT.
  • High purity (97.0%) suitable for research assays.
  • Supplied as a trihydrochloride salt for improved stability.
  • Available in small-scale quantities for screening, for example 50 MG.
  • Suitable for biochemical and cellular assay applications.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.